Atwood & Palmer’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $629 | Hold |
5
| – | – | ﹤0.01% | 492 |
|
|
2025
Q1 | $553 | Hold |
5
| – | – | ﹤0.01% | 422 |
|
|
2024
Q4 | $683 | Hold |
5
| – | – | ﹤0.01% | 448 |
|
|
2024
Q3 | $577 | Hold |
5
| – | – | ﹤0.01% | 448 |
|
|
2024
Q2 | $689 | Hold |
5
| – | – | ﹤0.01% | 421 |
|
|
2024
Q1 | $690 | Hold |
5
| – | – | ﹤0.01% | 399 |
|
|
2023
Q4 | $659 | Hold |
5
| – | – | ﹤0.01% | 384 |
|
|
2023
Q3 | $563 | Hold |
5
| – | – | ﹤0.01% | 382 |
|
|
2023
Q2 | $472 | Hold |
5
| – | – | ﹤0.01% | 384 |
|
|
2023
Q1 | $507 | Buy |
+5
| New | +$507 | ﹤0.01% | 358 |
|